Retrospective review of patient satisfaction and long-term uptake of Bone Conduction Hearing Devices in children with a unilateral congenital hearing loss.

2017 ◽  
Author(s):  
Rachel Hopkins
Keyword(s):  
Hearing Loss ◽  
Patient Satisfaction ◽  
Retrospective Review ◽  
Bone Conduction ◽  
Congenital Hearing Loss ◽  
Hearing Devices ◽  
Bone Conduction Hearing

Auditory Outcomes with Hearing Rehabilitation in Children with Unilateral Hearing Loss: A Systematic Review

2017 ◽  
Vol 157 (4) ◽  
pp. 565-571 ◽  
Author(s):  
Swathi Appachi ◽  
Jessica. L. Specht ◽  
Nikhila Raol ◽  
Judith E. C. Lieu ◽  
Michael S. Cohen ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Speech Recognition ◽  
Sound Localization ◽  
Hearing Aids ◽  
Bone Conduction ◽  
Unilateral Hearing Loss ◽  
Hearing Rehabilitation ◽  
Hearing Devices ◽  
Bone Conduction Hearing ◽  
Speech Recognition In Noise

Objective Options for management of unilateral hearing loss (UHL) in children include conventional hearing aids, bone-conduction hearing devices, contralateral routing of signal (CROS) aids, and frequency-modulating (FM) systems. The objective of this study was to systematically review the current literature to characterize auditory outcomes of hearing rehabilitation options in UHL. Data Sources PubMed, EMBASE, Medline, CINAHL, and Cochrane Library were searched from inception to January 2016. Manual searches of bibliographies were also performed. Review Methods Studies analyzing auditory outcomes of hearing amplification in children with UHL were included. Outcome measures included functional and objective auditory results. Two independent reviewers evaluated each abstract and article. Results Of the 249 articles identified, 12 met inclusion criteria. Seven articles solely focused on outcomes with bone-conduction hearing devices. Outcomes favored improved pure-tone averages, speech recognition thresholds, and sound localization in implanted patients. Five studies focused on FM systems, conventional hearing aids, or CROS hearing aids. Limited data are available but suggest a trend toward improvement in speech perception with hearing aids. FM systems were shown to have the most benefit for speech recognition in noise. Studies evaluating CROS hearing aids demonstrated variable outcomes. Conclusions Data evaluating functional and objective auditory measures following hearing amplification in children with UHL are limited. Most studies do suggest improvement in speech perception, speech recognition in noise, and sound localization with a hearing rehabilitation device.

Bone Conduction Implants: Transcutaneous vs. Percutaneous

1992 ◽  
Vol 106 (1) ◽  
pp. 68-74 ◽  
Author(s):  
Phillip S. Wade ◽  
Jerry J. Halik ◽  
Marshall Chasin
Keyword(s):  
Clinical Trial ◽  
Hearing Loss ◽  
Pure Tone ◽  
Conductive Hearing Loss ◽  
Bone Conduction ◽  
Mixed Hearing Loss ◽  
Hearing Devices ◽  
Bone Anchored Hearing Aid ◽  
Bone Conduction Hearing ◽  
Conductive Hearing

Clinical experience with transcutaneous bone conduction implants has demonstrated that they are most beneficial for patients with purely conductive hearing loss in at least one ear. Percutaneous bone conduction implants, however, have been reported to provide adequate benefit for patients with mixed hearing loss with bone conduction pure-tone averages up to 45 db hl (Tjellstrom, 1989). The results of 24 Xomed Audiant osseointegrated bone conduction hearing devices (including a clinical trial on two patients using a new, larger magnet [Neodynium Iron Boron]), plus the results of eleven patients implanted and fitted with the percutaneous bone-anchored hearing aid are reported. Aided results with these devices will be presented. In addition, general comparisons of benefit obtained with the two devices will be made for patients who exhibit similar hearing losses. Finally, a direct comparison will be made on two patients who have undergone both implant procedures.

scholarly journals Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®

2021 ◽  
Author(s):  
Ann-Kathrin Rauch ◽  
Thomas Wesarg ◽  
Antje Aschendorff ◽  
Iva Speck ◽  
Susan Arndt
Keyword(s):  
Hearing Loss ◽  
Bone Conduction ◽  
Speech Processor ◽  
Mixed Hearing Loss ◽  
Related Quality ◽  
Bone Conduction Hearing ◽  
Single Sided Deafness ◽  
Sound Processor ◽  
Term Data

Abstract Purpose The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulates the bone via a piezoelectric transducer and is directed by an external sound processor. We conducted a monocentric retrospective longitudinal within-subject clinical study at our tertiary academic referral center. The aim was to investigate long-term data (2017–2021) on audiological outcomes and hearing-related quality of life for the Osia system. Methods Between 2017 and 2020, 22 adults (18: CHL/MHL; 3: SSD) were implanted with the Osia100 implant; seven received bilateral implants. As of 10/2020, the sound processor was upgraded to Osia 2. Results Mean Osia system use by 04/2021 was 30.9 ± 8.6 months (range 17–40 months). Unaided bone conduction thresholds were unchanged postoperatively. One patient had to be explanted because of prolonged wound infection. Aided hearing thresholds were significantly lower compared to the unaided thresholds preoperatively, along with a marked increase in speech recognition in quiet. Speech processor upgrade resulted in a stable benefit. Patients with CHL/MHL and SSD showed a similar improvement in self-rated hearing performance revealed by SSQ, APHAB, and HUI questionnaires. Conclusion The Osia system is a safe, effective and sustainable option for treatment of conductive and mixed hearing loss or single-sided deafness.

scholarly journals Review of Bone Conduction Hearing Devices

2021 ◽  
Vol 11 (2) ◽  
pp. 207-219
Author(s):  
Susan E. Ellsperman ◽  
Emily M. Nairn ◽  
Emily Z. Stucken
Keyword(s):  
Hearing Aid ◽  
Bone Conduction ◽  
Sound Transmission ◽  
Ear Canal ◽  
Hearing Devices ◽  
Bone Conduction Hearing ◽  
Single Sided Deafness

Bone conduction is an efficient pathway of sound transmission which can be harnessed to provide hearing amplification. Bone conduction hearing devices may be indicated when ear canal pathology precludes the use of a conventional hearing aid, as well as in cases of single-sided deafness. Several different technologies exist which transmit sound via bone conduction. Here, we will review the physiology of bone conduction, the indications for bone conduction amplification, and the specifics of currently available devices.

Long-term Compliance and Satisfaction With Percutaneous Bone Conduction Devices in Patients With Congenital Unilateral Conductive Hearing Loss

2015 ◽  
Vol 36 (5) ◽  
pp. 826-833 ◽  
Author(s):  
Rik C. Nelissen ◽  
Emmanuel A. M. Mylanus ◽  
Cor W. R. J. Cremers ◽  
Myrthe K. S. Hol ◽  
Ad F. M. Snik
Keyword(s):  
Hearing Loss ◽  
Conductive Hearing Loss ◽  
Bone Conduction ◽  
Conductive Hearing

Ultrasound-Guided Placement of Percutaneous Abutments for Bone Conduction Hearing Devices

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Joseph T. Breen ◽  
Marc-Elie Nader ◽  
Paul W. Gidley
Keyword(s):  
Bone Conduction ◽  
Ultrasound Guided ◽  
Hearing Devices ◽  
Bone Conduction Hearing
Sign in / Sign up

Export Citation Format

Share Document